Interaction Guide · Research summary

Can I take S-Adenosylmethionine with Citalopram?

Review S-Adenosylmethionine with Citalopram: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Discuss SAMe with the prescriber before using it with citalopram. Official guidance raises a possible serotonergic interaction, although an exact-pair serotonin-syndrome rate is unknown.

What this answer covers

Oral S-adenosylmethionine supplement; concentrated supplement distinct from ordinary dietary nutrients.

Supplement or preparation
S-Adenosylmethionine
Medication ingredient
citalopram

Why review is reasonable

NCCIH cautions that SAMe may interact with medicines increasing serotonin. Citalopram has a serotonin-syndrome warning, although its label does not specifically name SAMe.

Clinical use is not universal safety proof

A small SAMe add-on trial in people taking serotonin-reuptake inhibitors found benefit. It does not establish citalopram-specific risk or rule out uncommon reactions.

Include mood history in the review

SAMe guidance highlights bipolar disorder concerns. Bring the complete supplement label and mood history before adding it.

Recognize concerning symptoms

Seek urgent medical care for a combination of agitation or confusion, fever or heavy sweating, tremor, muscle rigidity or repeated twitching. These can be signs of serotonin syndrome; a single nonspecific symptom does not establish the diagnosis.

Evidence and practical considerations

Side effects & toxicity

Conditional serotonergic review, with no demonstrated citalopram-specific event rate.

Exact scope
Oral S-adenosylmethionine supplement; concentrated supplement distinct from ordinary dietary nutrients. with Exact oral citalopram hydrobromide film-coated tablets. RxNorm IN2556 / PIN221078 hydrobromide tablets. Racemic citalopram is distinct from escitalopram.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • Mixed antidepressant augmentation evidence does not isolate citalopram safety.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral citalopram.

Label names tryptophan and St John’s wort in serotonin warnings; dose-dependent QT and electrolyte precautions are distinct from sedation and nutritional augmentation.

How this applies: RxNorm IN2556 / PIN221078 hydrobromide tablets. Racemic citalopram is distinct from escitalopram.

No universal supplement interval, event rate or preparation equivalence established.

Source 2: official supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering SAMe.

Possible interaction with serotonin-increasing medicines and supplements; bipolar disorder and limited long-term safety warrant review.

How this applies: Supplement-only precaution, applied conditionally with the citalopram label.

General possible serotonergic interaction and bipolar precautions; no citalopram-specific event rate.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 73 serotonin reuptake inhibitor nonresponders with major depression.

Response and remission favored SAMe; discontinuation due to adverse events was not significantly different.

How this applies: Indirect treatment context, not citalopram-specific safety or efficacy proof.

Mixed serotonin-reuptake-inhibitor trial; citalopram-specific exposure and outcomes not established from inspected text.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: 614fcfd7c28c8d87

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.